Effects of decreased insulin-like growth factor-1 stimulation on hypoxia inducible factor 1-α protein synthesis and function during cutaneous repair in diabetic mice

Wound Repair and Regeneration

Volumn 15, Issue 5, 2007, Pages 628-635

  Yu, Diana H ^a   MacE, Kimberly A ^a   Hansen, Scott L ^a   Boudreau, Nancy ^a   Young, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; RECOMBINANT SOMATOMEDIN C; REGULATOR PROTEIN; S6 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; WOUND HEALING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; FIBROBLASTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED STRAINS; RECEPTORS, LEPTIN; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 34848823534     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2007.00274.x     Document Type: Article

References (38)

1. Silhi N. Diabetes and wound healing. J Wound Care 1998 7 : 47 51.
2. Albertson S, Hummel RP III., Breeden M, Greenhalgh DG. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice. Surgery 1993 114 : 368 72 discussion 372-3.
3. Brown RL, Breeden MP, Greenhalgh DG. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse. J Surg Res 1994 56 : 562 70.
4. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990 136 : 1235 46.
5. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995 270 : 12607 13.
6. Werner S, Breeden M, Hubner G, Greenhalgh DG, Longaker MT. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. J Invest Dermatol 1994 103 : 469 73.
7. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999 341 : 738 46.
8. Brown DL, Kane CD, Chernausek SD, Greenhalgh DG. Differential expression and localization of insulin-like growth factor I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 1997 151 : 715 24.
9. Gartner MH, Benson JD, Caldwell MD. Insulin-like growth factors I and II expression in the healing wound. J Surg Res 1992 52 : 389 94.
10. Steenfos HH, Jansson JO. Gene expression of insulin-like growth factor-I and IGF-I receptor during wound healing in rats. Eur J Surg 1992 158 : 327 31.
11. Bitar MS. Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds. Surgery 2000 127 : 687 95.
12. Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW. Lack of insulin-like growth factor 1 (IGF I) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol 2000 190 : 589 94.
13. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002 277 : 38205 11.
14. Burroughs KD, Oh J, Barrett JC, DiAugustine RP. Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1? Mol Cancer Res 2003 1 : 312 22.
15. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002 64 : 993 8.
16. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003 3 : 721 32.
17. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY, Semenza GL. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998 12 : 149 62.
18. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997 272 : 5375 81.
19. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995 182 : 1683 93.
20. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001 7 : 345 50.
21. Semenza GL. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002 8 (Suppl. 4) : S62 7.
22. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL. Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000 60 : 1541 5.
23. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 alpha (HIF-1 alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001 21 : 3995 4004.
24. Proud CG. Regulation of mammalian translation factors by nutrients. Eur J Biochem 2002 269 : 5338 49.
25. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I, Avruch J. Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem 1997 272 : 26457 63.
26. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev 1999 13 : 1422 37.
27. Peterson RT, Desai BN, Hardwick JS, Schreiber SL. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc Natl Acad Sci USA 1999 96 : 4438 42.
28. Hansen SL, Myers CA, Charboneau A, Young DM, Boudreau N. Hox D3 accelerates wound healing in diabetic mice. Am J Pathol 2003 163 : 2421 31.
29. Hansen SL, Young DM, Boudreau NB. HoxD3 expression and collagen synthesis in diabetic fibroblasts. Wound Repair Regen 2003 11 : 474 80.
30. Tsuboi R, Shi CM, Sato C, Cox GN, Ogawa H. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J Invest Dermatol 1995 104 : 199 203.
31. Nakamura M, Kawahara M, Morishige N, Chikama T, Nakata K, Nishida T. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia 2003 46 : 839 42.
32. Brown DL, Kane CD, Chernausek SD, Greenhalgh DG. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 1997 151 : 715 24.
33. Bitar MS, Labbad ZN. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J Surg Res 1996 61 : 113 9.
34. Jeschke MG, Barrow RE, Hawkins HK, Yang K, Hayes RL, Lichtenbelt BJ, Perez-Polo JR, Herndon DN. IGF-I gene transfer in thermally injured rats. Gene Ther 1999 6 : 1015 20.
35. Beckert S, Hierlemann H, Muschenborn N, Witte M, Ranke M, Coerper S. Experimental ischemic wounds: correlation of cell proliferation and insulin-like growth factor I expression and its modification by different local IGF-I release systems. Wound Repair Regen 2005 13 : 278 83.
36. Hernon CA, Harrison CA, Thornton DJA, MacNeil S. Enhancement of keratinocyte performance in the production of tissue-engineered skin using a low-calcium medium. Wound Repair Regen 2007 (in press).
37. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 2005 15 : 57 63.
38. Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999 209 : 254 67.